Fig. 3.
Type 1 and 2, 5αR immunostaining in BPH, PIN, primary prostate cancer, recurrent cancer and metastases. Reproduced with permission from Thomas et al.21
Type 1 and 2, 5αR immunostaining in BPH, PIN, primary prostate cancer, recurrent cancer and metastases. Reproduced with permission from Thomas et al.21